5 EASY FACTS ABOUT HEMGENIX DESCRIBED

Variety of qualified sufferers: CDEC talked about the uncertainty in the quantity of sufferers with moderately extreme to extreme hemophilia B in Canada eligible for etranacogene dezaparvovec. Scientific experts consulted by CADTH indicated that some patients who will be categorised as acquiring delicate or moderate disease may have a severe bleedi